Sign In
Buy DXCM
$72.77
-0.680 (-0.93%)
At Close: Jun 03, 2026
Exchange Traded Concepts LLC Sells 8,031 Shares of DexCom, Inc. $DXCM
03:40am, Wednesday, 08'th Apr 2026
Exchange Traded Concepts LLC lessened its position in shares of DexCom, Inc. (NASDAQ: DXCM) by 80.1% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Com
Financial Analysis: Pacific Biosciences of California (NASDAQ:PACB) versus DexCom (NASDAQ:DXCM)
01:40am, Tuesday, 07'th Apr 2026
Pacific Biosciences of California (NASDAQ: PACB - Get Free Report) and DexCom (NASDAQ: DXCM - Get Free Report) are both medical companies, but which is the superior business? We will contrast the two
Banque Pictet & Cie SA Raises Stock Holdings in DexCom, Inc. $DXCM
03:30am, Friday, 03'rd Apr 2026
Banque Pictet and Cie SA boosted its holdings in shares of DexCom, Inc. (NASDAQ: DXCM) by 58.2% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange C
Dexcom Schedules First Quarter 2026 Earnings Release and Conference Call for April 30, 2026 at 4:30 p.m. Eastern Time
08:30am, Thursday, 02'nd Apr 2026
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its first quarter 2026 financial results after market close on Thursday, April 30, 2026. Management will
DexCom, Inc. $DXCM Shares Sold by Beacon Investment Advisory Services Inc.
03:35am, Monday, 30'th Mar 2026
Beacon Investment Advisory Services Inc. reduced its stake in DexCom, Inc. (NASDAQ: DXCM) by 12.1% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Ex
Contrasting DexCom (NASDAQ:DXCM) and LENSAR (NASDAQ:LNSR)
02:42am, Saturday, 28'th Mar 2026
DexCom (NASDAQ: DXCM - Get Free Report) and LENSAR (NASDAQ: LNSR - Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the streng
Sysmex (OTCMKTS:SSMXY) vs. DexCom (NASDAQ:DXCM) Head to Head Survey
01:15am, Saturday, 28'th Mar 2026
Sysmex (OTCMKTS:SSMXY - Get Free Report) and DexCom (NASDAQ: DXCM - Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on the st
Why DexCom (DXCM) is a Top Growth Stock for the Long-Term
10:46am, Wednesday, 25'th Mar 2026
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
DexCom, Inc. $DXCM Shares Acquired by Gradient Investments LLC
06:27am, Monday, 23'rd Mar 2026
Gradient Investments LLC boosted its holdings in DexCom, Inc. (NASDAQ: DXCM) by 13.8% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 332,006 shares of
Touchstone Sands Capital Select Growth Fund Q4 2025 Portfolio Review
03:08pm, Tuesday, 17'th Mar 2026
The Touchstone Sands Capital Select Growth Fund (Class A Shares, Load Waived) underperformed its benchmark, the Russell 1000® Growth Index, for the quarter ended December 31, 2025. Security selection
Here's Why You Should Hold DexCom Stock in Your Portfolio for Now
03:45pm, Monday, 16'th Mar 2026
DXCM gains from CGM demand, Medicare coverage expansion and its new G7 15-day sensor, but rising competition and manufacturing investments may pressure margins.
Cinctive Capital Management LP Takes $4.45 Million Position in DexCom, Inc. $DXCM
05:02am, Monday, 16'th Mar 2026
Cinctive Capital Management LP purchased a new stake in shares of DexCom, Inc. (NASDAQ: DXCM) during the undefined quarter, according to its most recent disclosure with the SEC. The fund purchased 66,
Bamco Inc. NY Reduces Stock Position in DexCom, Inc. $DXCM
04:23am, Monday, 16'th Mar 2026
Bamco Inc. NY decreased its holdings in DexCom, Inc. (NASDAQ: DXCM) by 18.0% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commissio
Why DexCom (DXCM) is a Top Momentum Stock for the Long-Term
10:51am, Friday, 13'th Mar 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Dexcom Showcases Breakthrough Outcomes for People With Type 2 Diabetes and Product Roadmap at ATTD 2026
02:00am, Wednesday, 11'th Mar 2026
BARCELONA, Spain--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, will present new findings that showcase the benefits of its glucose biosensing technology for pe
